Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Call for Papers - AI in Dementia

AI in Dementia Research

Alzheimer's Research & Therapy invites submissions for a thematic series focusing on the use of artificial intelligence, machine learning and related techniques in dementia research. 

Find out more about the series and how to submit here.

Announcing the launch of In Review

In partnership with Research SquareAlzheimer's Research & Therapy is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Read more about the full range of benefits of In Review and how to opt in, or see the In Review platform for yourself here.


  1. Authors: Justin S. Sanchez, Bernard J. Hanseeuw, Francisco Lopera, Reisa A. Sperling, Ana Baena, Yamile Bocanegra, David Aguillon, Edmarie Guzmán-Vélez, Enmanuelle Pardilla-Delgado, Liliana Ramirez-Gomez, Clara Vila-Castelar, Jairo E. Martinez, Joshua T. Fox-Fuller, Claudia Ramos, Martin Ochoa-Escudero, Sergio Alvarez…

    Content type: Research

Early Career Researcher Reviewer Panel

New Content Item

Interested in an introduction to peer reviewing articles for Alzheimer's Research & Therapy?

Find out more about our ECR Peer Reviewer Panel!

Aims and scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Affiliated with

Annual Journal Metrics